These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33533305)

  • 1. Progesterone-induced blocking factor improves blood pressure, inflammation, and pup weight in response to reduced uterine perfusion pressure (RUPP).
    Cottrell JN; Witcher AC; Comley K; Cunningham MW; Ibrahim T; Cornelius DC; LaMarca B; Amaral LM
    Am J Physiol Regul Integr Comp Physiol; 2021 May; 320(5):R719-R727. PubMed ID: 33533305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy.
    Deer E; Jones J; Cornelius DC; Comley K; Herrock O; Campbell N; Fitzgerald S; Ibrahim T; LaMarca B; Amaral LM
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4 supplementation improves the pathophysiology of hypertension in response to placental ischemia in RUPP rats.
    Cottrell JN; Amaral LM; Harmon A; Cornelius DC; Cunningham MW; Vaka VR; Ibrahim T; Herse F; Wallukat G; Dechend R; LaMarca B
    Am J Physiol Regul Integr Comp Physiol; 2019 Feb; 316(2):R165-R171. PubMed ID: 30624978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone-induced blocking factor blockade causes hypertension in pregnant rats.
    Meadors A; Comley K; Cottrell JN; Ibhahim T; Cunningham MW; Amaral LM
    Am J Reprod Immunol; 2024 Jan; 91(1):e13805. PubMed ID: 38282604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells mediate pathophysiology in response to reduced uterine perfusion pressure.
    Elfarra J; Amaral LM; McCalmon M; Scott JD; Cunningham MW; Gnam A; Ibrahim T; LaMarca B; Cornelius DC
    Clin Sci (Lond); 2017 Dec; 131(23):2753-2762. PubMed ID: 29042488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon γ neutralization reduces blood pressure, uterine artery resistance index, and placental oxidative stress in placental ischemic rats.
    Travis OK; Tardo GA; Giachelli C; Siddiq S; Nguyen HT; Crosby MT; Johnson TD; Brown AK; Booz GW; Smith AN; Williams JM; Cornelius DC
    Am J Physiol Regul Integr Comp Physiol; 2021 Aug; 321(2):R112-R124. PubMed ID: 34075808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-17 signaling mediates cytolytic natural killer cell activation in response to placental ischemia.
    Travis OK; White D; Baik C; Giachelli C; Thompson W; Stubbs C; Greer M; Lemon JP; Williams JM; Cornelius DC
    Am J Physiol Regul Integr Comp Physiol; 2020 Jun; 318(6):R1036-R1046. PubMed ID: 32320265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17-Hydroxyprogesterone caproate improves T cells and NK cells in response to placental ischemia; new mechanisms of action for an old drug.
    Elfarra JT; Cottrell JN; Cornelius DC; Cunningham MW; Faulkner JL; Ibrahim T; Lamarca B; Amaral LM
    Pregnancy Hypertens; 2020 Jan; 19():226-232. PubMed ID: 31806502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced uterine perfusion pressure T-helper 17 cells cause pathophysiology associated with preeclampsia during pregnancy.
    Cornelius DC; Amaral LM; Wallace K; Campbell N; Thomas AJ; Scott J; Herse F; Wallukat G; Dechend R; LaMarca B
    Am J Physiol Regul Integr Comp Physiol; 2016 Dec; 311(6):R1192-R1199. PubMed ID: 27784685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model.
    Amaral LM; Cornelius DC; Harmon A; Moseley J; Martin JN; LaMarca B
    Hypertension; 2015 Jan; 65(1):225-31. PubMed ID: 25368030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
    Ren Z; Cui N; Zhu M; Khalil RA
    Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-33 supplementation improves uterine artery resistance and maternal hypertension in response to placental ischemia.
    Wang X; Shields C; Tardo G; Peacock G; Hester E; Anderson M; Williams JM; Cornelius DC
    Am J Physiol Heart Circ Physiol; 2024 Apr; 326(4):H1006-H1016. PubMed ID: 38363211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cells contribute to mitochondrial dysfunction in response to placental ischemia in reduced uterine perfusion pressure rats.
    Vaka VR; McMaster KM; Cornelius DC; Ibrahim T; Jayaram A; Usry N; Cunningham MW; Amaral LM; LaMarca B
    Am J Physiol Regul Integr Comp Physiol; 2019 May; 316(5):R441-R447. PubMed ID: 30811248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Necrosis Factor-alpha Blockade Improves Uterine Artery Resistance, Maternal Blood Pressure, and Fetal Growth in Placental Ischemic Rats.
    Travis OK; Tardo GA; Giachelli C; Siddiq S; Nguyen HT; Crosby MT; Johnson T; Brown AK; Williams JM; Cornelius DC
    Pregnancy Hypertens; 2021 Aug; 25():39-47. PubMed ID: 34051437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive transfer of placental ischemia-stimulated natural killer cells causes a preeclampsia-like phenotype in pregnant rats.
    Travis OK; Baik C; Tardo GA; Amaral L; Jackson C; Greer M; Giachelli C; Ibrahim T; Herrock OT; Williams JM; Cornelius DC
    Am J Reprod Immunol; 2021 Jun; 85(6):e13386. PubMed ID: 33315281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serelaxin improves the pathophysiology of placental ischemia in the reduced uterine perfusion pressure rat model of preeclampsia.
    Santiago-Font JA; Amaral LM; Faulkner J; Ibrahim T; Vaka VR; Cunningham MW; LaMarca B
    Am J Physiol Regul Integr Comp Physiol; 2016 Dec; 311(6):R1158-R1163. PubMed ID: 27629886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of interleukin-2-mediated changes in blood pressure, fetal growth restriction, and innate immune activation in normal pregnant rats and in a preclinical rat model of preeclampsia.
    Cunningham MW; Amaral LM; Campbell NE; Cornelius DC; Ibrahim T; Vaka VR; LaMarca B
    Biol Sex Differ; 2021 Jan; 12(1):4. PubMed ID: 33407826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental ischemia-stimulated T-helper 17 cells induce preeclampsia-associated cytolytic natural killer cells during pregnancy.
    Shields CA; McCalmon M; Ibrahim T; White DL; Williams JM; LaMarca B; Cornelius DC
    Am J Physiol Regul Integr Comp Physiol; 2018 Aug; 315(2):R336-R343. PubMed ID: 29718698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system.
    Wallace K; Novotny S; Heath J; Moseley J; Martin JN; Owens MY; LaMarca B
    Am J Physiol Regul Integr Comp Physiol; 2012 Jul; 303(2):R144-9. PubMed ID: 22647295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUPP Th17s cause hypertension and mitochondrial dysfunction in the kidney and placenta during pregnancy.
    Fitzgerald S; Deer E; Hogg J; Cornelius DC; Turner T; Amaral LM; Hoang N; Edwards K; Herrock O; Campbell N; Ibrahim T; LaMarca B
    Pregnancy Hypertens; 2023 Jun; 32():50-56. PubMed ID: 37104924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.